Why I’d sell Royal Bank of Scotland Group plc to buy its fast-growing supplier

After rising over 45% in the past year, it may be time to ditch Royal Bank of Scotland Group plc (LON: RBS).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The headline on the Financial Times article about Royal Bank of Scotland’s (LSE: RBS) Q3 results this morning ran ‘RBS swings into profit as bank draws line under financial crisis’. Yes, it took a mere decade but the bank is finally back in the black.

Well, sort of. Management isn’t targeting its first annual profit since 2007 until next year and qualifies that this target is based on the still-to-be-decided size of its expected multi-billion-pound settlement with the US Department of Justice over the mis-selling of mortgage backed securities in the dark days of the financial crisis.

There’s still no concrete timeframe for when this settlement will conclude, but some analysts expect it to be twice the £4.2bn payout agreed with the Federal Housing Finance Agency earlier this year. The bank has already stashed £2.8bn for the expected fine, but if it’s substantially over this mark, expect that first annual profit to be pushed back yet another year.

That said, management is doing well in fixing the issues it actually has agency over. In the first nine months of the year, its heavily adjusted cost-to-income ratio fell from 65.9% to 53.9%, while its statutory return on tangible equity (RoE) flipped from a substantial negative to 5.2%. This means the bank’s 2020 target of a sub 50% cost-to-income ratio and RoE over 12% remain achievable.

However, there is still a lot of heavy lifting to be done. With the mega-fine threatening to wipe out several years’ worth of underlying profits, plenty of costly restructuring still ahead, and the prize at the end of the road a highly competitive retail banking market with low interest rates equalling low profitability, I see many better places to invest my money than RBS, even if it is finally, possibly, back on the right track.    

An already profitable alternative 

Much more attractive to me is a supplier of RBS, Alfa Financial Software (LSE: ALFA). The tech firm provides software to the asset finance sector, which covers everything from consumer auto loans to firms purchasing machinery on credit.

As the regularly shambolic performance of big banks’ IT systems illustrates, the finance industry does not have a great track record of designing its own software. That’s where Alfa comes in, with a cloud and computer-based platform that is tailored to a customer’s specific needs and often comes with a price tag much lower than doing it in-house.

Unsurprisingly, this offer has been a hit with car companies, banks and even Uber. In the half year to June, its first reporting period as a public company, revenue was up 29% in constant currency terms to £43.9m while adjusted operating profits were up 20% to £20.2m.

More than half of the firm’s revenue comes from the early years of a contract as it works to embed its software in clients’ systems and train their personnel in using it. However, over the long term, there is considerable potential for Alfa to increase its percentage of recurring revenue, which brought in £10m in H1 compared to only £2.4m in the year prior.

Alfa’s shares aren’t cheap at 45 times forward earnings but with no debt, high profitability and huge growth potential, I see plenty to like.  

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »